Dyspneic and non-dyspneic (silent) hypoxemia in COVID-19: Possible neurological mechanism

[1]  Masoud Nouri-Vaskeh,et al.  Angiotensin 1-7: A Novel Strategy in COVID-19 Treatment , 2020, Advanced pharmaceutical bulletin.

[2]  Pardis C Sabeti,et al.  Neuropathological Features of Covid-19 , 2020, The New England journal of medicine.

[3]  M. Dalakas.  Guillain-Barré syndrome: The first documented COVID-19–triggered autoimmune neurologic disease , 2020, Neurology: Neuroimmunology & Neuroinflammation.

[4]  S. Farhadian,et al.  Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review. , 2020, JAMA neurology.

[5]  J. Laínez,et al.  An Online Observational Study of Patients With Olfactory and Gustory Alterations Secondary to SARS-CoV-2 Infection , 2020, Frontiers in Public Health.

[6]  R. Nicholas,et al.  COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia , 2020, Neurology: Neuroimmunology & Neuroinflammation.

[7]  J. Matias‐Guiu,et al.  Is the brain a reservoir organ for SARS‐CoV2? , 2020, Journal of medical virology.

[8]  A. Priori,et al.  First ultrastructural autoptic findings of SARS-Cov-2 in olfactory pathways and brainstem. , 2020, Minerva anestesiologica.

[9]  Y. Huang,et al.  SARS-CoV-2 Detected in Cerebrospinal Fluid by PCR in a Case of COVID-19 Encephalitis , 2020, Brain, Behavior, and Immunity.

[10]  Marco Maria Fontanella,et al.  SARS-CoV-2 can induce brain and spine demyelinating lesions , 2020, Acta Neurochirurgica.

[11]  I. Appollonio,et al.  Guillain-Barré syndrome related to COVID-19 infection , 2020, Neurology: Neuroimmunology & Neuroinflammation.

[12]  Xiaosheng Wang,et al.  Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues , 2020, Infectious Diseases of Poverty.

[13]  Samir Abu-Rumeileh,et al.  Guillain-Barré syndrome following COVID-19: new infection, old complication? , 2020, Journal of Neurology.

[14]  M. Fowkes,et al.  Central nervous system involvement by severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) , 2020, Journal of medical virology.

[15]  H. Thiele,et al.  Ventilation of COVID-19 patients in intensive care units , 2020, Herz.

[16]  M. Balaan,et al.  Guillain-Barré Syndrome associated with SARS-CoV-2 infection , 2020, IDCases.

[17]  Hong Shan,et al.  A Clinical Study of Noninvasive Assessment of Lung Lesions in Patients with Coronavirus Disease-19 (COVID-19) by Bedside Ultrasound , 2020, Ultraschall in der Medizin - European Journal of Ultrasound.

[18]  G. Manley,et al.  Smell and taste dysfunction in patients with COVID-19 , 2020, The Lancet Infectious Diseases.

[19]  J. Q. Brown,et al.  Pulmonary and Cardiac Pathology in Covid-19: The First Autopsy Series from New Orleans , 2020, medRxiv.

[20]  L. French,et al.  The Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in the Human and Mouse Brains , 2020, bioRxiv.

[21]  C. Eloit,et al.  Sudden and Complete Olfactory Loss Function as a Possible Symptom of COVID-19. , 2020, JAMA otolaryngology-- head & neck surgery.

[22]  R. Carlier,et al.  Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study , 2020, European Archives of Oto-Rhino-Laryngology.

[23]  N. Enomoto,et al.  A first case of meningitis/encephalitis associated with SARS-Coronavirus-2 , 2020, International Journal of Infectious Diseases.

[24]  C. Hopkins,et al.  Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome? , 2020, Rhinology.

[25]  J. Matías-Guiu,et al.  ¿Es esperable que haya cuadros neurológicos por la pandemia por SARS-CoV-2? , 2020, Neurología.

[26]  Masoud Nouri-Vaskeh,et al.  Fecal transmission in COVID‐19: A potential shedding route , 2020, Journal of medical virology.

[27]  L. Vaira,et al.  Anosmia and Ageusia: Common Findings in COVID‐19 Patients , 2020, The Laryngoscope.

[28]  Massimo Cressoni,et al.  COVID-19 Does Not Lead to a “Typical” Acute Respiratory Distress Syndrome , 2020, American journal of respiratory and critical care medicine.

[29]  S. Chew,et al.  Olfactory cell cultures to investigate health effects of air pollution exposure: Implications for neurodegeneration , 2020, Neurochemistry International.

[30]  Shuke Nie,et al.  Acute myelitis after SARS-CoV-2 infection: a case report. , 2020, medRxiv.

[31]  X. Bian,et al.  [A pathological report of three COVID-19 cases by minimally invasive autopsies]. , 2020, Zhonghua bing li xue za zhi = Chinese journal of pathology.

[32]  Fabian J Theis,et al.  SARS-CoV-2 Entry Genes Are Most Highly Expressed in Nasal Goblet and Ciliated Cells within Human Airways , 2020, Nature Medicine.

[33]  Usman Ali,et al.  Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host–Virus Interaction, and Proposed Neurotropic Mechanisms , 2020, ACS chemical neuroscience.

[34]  D. Wang,et al.  The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status , 2020, Military Medical Research.

[35]  Xiang Xie,et al.  COVID-19 and the cardiovascular system , 2020, Nature Reviews Cardiology.

[36]  Tsutomu Hashikawa,et al.  The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients , 2020, Journal of medical virology.

[37]  Shengqing Wan,et al.  Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations , 2020, Cell Discovery.

[38]  Shengqing Wan,et al.  Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations , 2020, Cell Discovery.

[39]  Jiyuan Zhang,et al.  Pathological findings of COVID-19 associated with acute respiratory distress syndrome , 2020, The Lancet Respiratory Medicine.

[40]  T. Burki.  Outbreak of coronavirus disease 2019 , 2020, The Lancet Infectious Diseases.

[41]  M. Sarkar,et al.  Mechanisms of hypoxemia , 2017, Lung India : official organ of Indian Chest Society.

[42]  S. Lanigan,et al.  The Effects of Hypoxia and Inflammation on Synaptic Signaling in the CNS , 2016, Brain sciences.

[43]  C. Büchel,et al.  Brain mechanisms of short-term habituation and sensitization toward dyspnea , 2015, Front. Psychol..

[44]  A. Corcoran,et al.  Hypoxia‐inducible factor signalling mechanisms in the central nervous system , 2013, Acta physiologica.

[45]  M. Ivan,et al.  miR‐210: More than a silent player in hypoxia , 2011, IUBMB life.

[46]  Lu-Yuan Lee,et al.  Mechanisms of dyspnea. , 2010, Chest.

[47]  F. Gigliotti.  Mechanisms of dyspnea in healthy subjects , 2010, Multidisciplinary respiratory medicine.

[48]  Paul W. Davenport,et al.  Cortical and subcortical central neural pathways in respiratory sensations , 2009, Respiratory Physiology & Neurobiology.

[49]  James P. Evans.  The Origin , 2009, Genetics in Medicine.

[50]  A. Harris,et al.  Hypoxia response and microRNAs: no longer two separate worlds , 2008, Journal of cellular and molecular medicine.

[51]  David K. Meyerholz,et al.  Severe Acute Respiratory Syndrome Coronavirus Infection Causes Neuronal Death in the Absence of Encephalitis in Mice Transgenic for Human ACE2 , 2008, Journal of Virology.

[52]  Christian Büchel,et al.  The unpleasantness of perceived dyspnea is processed in the anterior insula and amygdala. , 2008, American journal of respiratory and critical care medicine.

[53]  Nicolas Costes,et al.  Relief of dyspnea involves a characteristic brain activation and a specific quality of sensation. , 2008, American journal of respiratory and critical care medicine.

[54]  R. Niven,et al.  Disproportionate breathlessness associated with deep sighing breathing in a patient presenting with difficult-to-treat asthma. , 2006, Chest.

[55]  Bernhard Dahme,et al.  Cortical substrates for the perception of dyspnea. , 2005, Chest.

[56]  I. Biaggioni,et al.  Hypoxia Modulates Adenosine Receptors in Human Endothelial and Smooth Muscle Cells Toward an A2B Angiogenic Phenotype , 2004, Hypertension.

[57]  D. Pierson,et al.  Mechanisms of hypoxemia. , 2000, Respiratory care clinics of North America.

[58]  G. Semenza,et al.  Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 , 1996, Molecular and cellular biology.

[59]  A. Bühlmann.  [Pathophysiology of dyspnea]. , 1989, Schweizerische medizinische Wochenschrift.

[60]  P. Lipton,et al.  The effect of hypoxia on evoked potentials in the in vitro hippocampus. , 1979, The Journal of physiology.

[61]  G. Wright,et al.  The origin of the sensations of dyspnea. , 1954, Transactions of the American Clinical and Climatological Association.